Aclaris Therapeutics Management
Management criteria checks 3/4
Aclaris Therapeutics' CEO is Neal Walker, appointed in Jul 2012, has a tenure of 11.75 years. total yearly compensation is $73.50K, comprised of 802.3% salary and -702.3% bonuses, including company stock and options. directly owns 1.81% of the company’s shares, worth $1.55M. The average tenure of the management team and the board of directors is 1.8 years and 9.9 years respectively.
Key information
Neal Walker
Chief executive officer
US$73.5k
Total compensation
CEO salary percentage | 802.3% |
CEO tenure | 11.8yrs |
CEO ownership | 1.8% |
Management average tenure | 1.8yrs |
Board average tenure | 9.9yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
Date | Total Compensation | Salary | Company Earnings |
---|---|---|---|
Dec 31 2023 | US$74k | n/a | -US$88m |
Sep 30 2023 | n/a | n/a | -US$115m |
Jun 30 2023 | n/a | n/a | -US$105m |
Mar 31 2023 | n/a | n/a | -US$96m |
Dec 31 2022 | US$6m | US$590k | -US$87m |
Sep 30 2022 | n/a | n/a | -US$82m |
Jun 30 2022 | n/a | n/a | -US$83m |
Mar 31 2022 | n/a | n/a | -US$81m |
Dec 31 2021 | US$7m | US$567k | -US$91m |
Sep 30 2021 | n/a | n/a | -US$82m |
Jun 30 2021 | n/a | n/a | -US$71m |
Mar 31 2021 | n/a | n/a | -US$65m |
Dec 31 2020 | US$2m | US$424k | -US$51m |
Sep 30 2020 | n/a | n/a | -US$57m |
Jun 30 2020 | n/a | n/a | -US$69m |
Mar 31 2020 | n/a | n/a | -US$102m |
Dec 31 2019 | US$3m | US$500k | -US$114m |
Sep 30 2019 | n/a | n/a | -US$118m |
Jun 30 2019 | n/a | n/a | -US$115m |
Mar 31 2019 | n/a | n/a | -US$79m |
Dec 31 2018 | US$4m | US$550k | -US$82m |
Sep 30 2018 | n/a | n/a | -US$81m |
Jun 30 2018 | n/a | n/a | -US$79m |
Mar 31 2018 | n/a | n/a | -US$86m |
Dec 31 2017 | US$810k | US$510k | -US$50m |
Compensation vs Market: Neal's total compensation ($USD73.50K) is below average for companies of similar size in the UK market ($USD344.94K).
Compensation vs Earnings: Neal's compensation has been consistent with company performance over the past year.
CEO
Neal Walker (53 yo)
11.8yrs
Tenure
US$73,500
Compensation
Dr. Neal S. Walker, D.O. & M.D., is Venture Partner of Forge Life Science Partners. He Co-founded Aclaris Therapeutics, Inc. in 2012 and has been its Director since July 2012 and serves as its Chairman sin...
Leadership Team
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Co-Founder | 11.8yrs | US$73.50k | 1.81% $ 1.6m | |
Chief Financial Officer | 1.3yrs | US$2.34m | 0.034% $ 28.9k | |
Chief Scientific Officer | 3.3yrs | US$2.26m | 0.26% $ 225.4k | |
Chief Business Officer | 2.3yrs | US$2.33m | 0.048% $ 41.0k | |
General Counsel & Corporate Secretary | 1.8yrs | no data | no data | |
Senior Vice President of Chemistry | no data | no data | no data | |
Senior Vice President of Project Leadership | less than a year | no data | no data | |
Senior Vice President of Clinical Development | less than a year | no data | no data |
1.8yrs
Average Tenure
55.5yo
Average Age
Experienced Management: 0H8T's management team is not considered experienced ( 1.8 years average tenure), which suggests a new team.
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Co-Founder | 11.8yrs | US$73.50k | 1.81% $ 1.6m | |
Independent Director | 4.3yrs | US$180.38k | 0.011% $ 9.5k | |
Member of Advisory Board | no data | no data | no data | |
Member of Advisory Board | no data | no data | no data | |
Member of Advisory Board | no data | no data | no data | |
Independent Director | 9.6yrs | US$194.38k | 0.055% $ 46.7k | |
Member of Advisory Board | no data | no data | no data | |
Member of Advisory Board | no data | no data | no data | |
Lead Independent Director | 10.3yrs | US$206.88k | 0.068% $ 58.5k | |
Member of Advisory Board | no data | no data | no data | |
Member of Advisory Board | no data | no data | no data | |
Member of Advisory Board | no data | no data | no data |
9.9yrs
Average Tenure
59yo
Average Age
Experienced Board: 0H8T's board of directors are considered experienced (9.9 years average tenure).